Authors: Alessandro Cicchetti1, Nuradh Joseph2, Petra Seibold3, Barbara Avuzzi4, Riccardo Valdagni5, Adam Webb6, Dirk De Ruysscher7, Maarten Lambrecht8, Elena Sperk9, Rebecca Elliott10, Christopher Talbot11, Liv Veldeman12, Jenny Chang-Claude3, Ananya Choudhury13, Ana Vega14, David Azria15, Tiziana Rancati16, Catharine West17
1Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Prostate Cancer Program, Milan, Italy; 2General Hospital Chilaw, Ministry of Health, Chilaw, Sri Lanka; 3German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany; 4Fondazione IRCCS Istituto Tumori di Milano, Radiation Oncology 1, Milan, Italy; 5University of Milan, Department oncology and hematoncology, Milan, Italy; 6University of Leicester, Department of Genetics and Genome Biology, Leicester, United Kingdom; 7Maastricht University Medical Center, Department of Radiation Oncology, Maastricht, Belgium; 8University Hospitals Leuven, -, Leuven, Belgium; 9University of Heidelberg, Department of Radiation Oncology, Mannheim,, Germany; 10 University of Manchester, Translational Radiobiology Group, Division of Cancer Sciences, Manchester, United Kingdom; 11University of Leicester, Leicester Cancer Research Centre,, Leicester, United Kingdom; 12Ghent University, Department of Human Structure and Repai, Ghent, Belgium; 13University of Manchester, Christie Hospital, Division of Cancer Sciences Translational Radiobiology Group, Manchester, United Kingdom; 14Fundación Pública Galega de Medicina Xenómica, Grupo de Medicina Xenómica (USC), Santiago de Compostela, Spain; 15Montpellier Cancer Institute, Department of Radiation Oncology, Montpellier, France; 16Fondazione IRCCS Istituto Nazionale dei Tumori, Prostate Cancer Program, milan, Italy; 17 University of Manchester, Manchester Academic Health Science Centre,, Translational Radiobiology Group, Division of Cancer Sciences,, Manchester, United Kingdom
Show Affiliations
Hide Affiliations